wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38137750-5B989B1A-7B6A-4DC8-B17E-86D90F8348B3
Q38137750-5B989B1A-7B6A-4DC8-B17E-86D90F8348B3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38137750-5B989B1A-7B6A-4DC8-B17E-86D90F8348B3
Are MPNs vascular diseases?
P2860
Q38137750-5B989B1A-7B6A-4DC8-B17E-86D90F8348B3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38137750-5B989B1A-7B6A-4DC8-B17E-86D90F8348B3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
475908604bd1e3a8079a26bf6544cde8c2991820
P2860
JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis.